CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
THIRD QUARTER 2014 (JUL – SEP) • Net sales in the quarter amounted to SEK 22.4 (16.8) million, corresponding to an increase of 34 percent.• Net sales for consumables in the quarter amounted to SEK 21.0 (16.8) million, corresponding to an increase of 25 percent in SEK. Sales for consumables increased by 18 percent in local currency.• Operating income before depreciation and amortization (EBITDA) amounted to SEK 3.4 (3.8) million, corresponding to an EBITDA margin of 15 percent.• Net income amounted to SEK 1.5 (1.6) million, resulting in earnings per share of SEK 0.07 (0.08).•